AU7268000A - Method for quantization of the antiviral effect of antiviral active principles - Google Patents

Method for quantization of the antiviral effect of antiviral active principles

Info

Publication number
AU7268000A
AU7268000A AU72680/00A AU7268000A AU7268000A AU 7268000 A AU7268000 A AU 7268000A AU 72680/00 A AU72680/00 A AU 72680/00A AU 7268000 A AU7268000 A AU 7268000A AU 7268000 A AU7268000 A AU 7268000A
Authority
AU
Australia
Prior art keywords
antiviral
quantization
active principles
effect
antiviral effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU72680/00A
Inventor
Martin Heinkelein
Gergely Jarmy
Christian Jassoy
Axel Rethwilm
Benedikt Weissbrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GASSOY CHRISTIAN
Original Assignee
GASSOY CHRISTIAN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19951327A external-priority patent/DE19951327A1/en
Application filed by GASSOY CHRISTIAN filed Critical GASSOY CHRISTIAN
Publication of AU7268000A publication Critical patent/AU7268000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU72680/00A 1999-07-21 2000-07-19 Method for quantization of the antiviral effect of antiviral active principles Abandoned AU7268000A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19934917 1999-07-21
DE19934917 1999-07-21
DE19951327A DE19951327A1 (en) 1999-07-21 1999-10-20 Quantifying activity of antiviral agents, useful for drug discovery, by expression of marker genes in cells transduced with attenuated viral vector
DE19951327 1999-10-20
PCT/DE2000/002428 WO2001007646A2 (en) 1999-07-21 2000-07-19 Method for quantization of the antiviral effect of antiviral active principles

Publications (1)

Publication Number Publication Date
AU7268000A true AU7268000A (en) 2001-02-13

Family

ID=26054336

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72680/00A Abandoned AU7268000A (en) 1999-07-21 2000-07-19 Method for quantization of the antiviral effect of antiviral active principles

Country Status (2)

Country Link
AU (1) AU7268000A (en)
WO (1) WO2001007646A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9067966B2 (en) 2009-07-14 2015-06-30 Hetero Research Foundation, Hetero Drugs Ltd. Lupeol-type triterpene derivatives as antivirals
WO2011061590A1 (en) 2009-11-17 2011-05-26 Hetero Research Foundation Novel carboxamide derivatives as hiv inhibitors
WO2011080562A1 (en) 2009-12-29 2011-07-07 Hetero Research Foundation Novel aza-peptides containing 2,2-disubstituted cyclobutyl and/or substituted alkoxy benzyl derivatives as antivirals
WO2012095705A1 (en) 2011-01-10 2012-07-19 Hetero Research Foundation Pharmaceutically acceptable salts of novel betulinic acid derivatives
WO2014105926A1 (en) 2012-12-31 2014-07-03 Hetero Research Foundation Novel betulinic acid proline derivatives as hiv inhibitors
US20170129916A1 (en) 2014-06-26 2017-05-11 Hetero Research Foundation Novel betulinic proline imidazole derivatives as hiv inhibitors
MA40886B1 (en) 2015-02-09 2020-03-31 Hetero Research Foundation Novel c-3 triterpenone with c-28 reverse amide derivatives as hiv inhibitors
WO2016147099A2 (en) 2015-03-16 2016-09-22 Hetero Research Foundation C-3 novel triterpenone with c-28 amide derivatives as hiv inhibitors
CA3129743A1 (en) 2019-02-11 2020-08-20 Hetero Labs Limited Novel triterpene derivatives as hiv inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE118247T1 (en) * 1988-09-27 1995-02-15 Dana Farber Cancer Inst Inc VECTOR CONTAINING A REPLICATION COMPETENT HIV-I PROVIRUS AND A HETEROLOGUE GENE.
CA2084659A1 (en) * 1990-06-20 1991-12-21 Joseph G. Sodroski Vectors containing hiv packaging sequences, packaging defective hiv vectors, and uses thereof
US5837464A (en) * 1996-01-29 1998-11-17 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
KR100246096B1 (en) * 1996-09-21 2000-03-15 이선경 Improved retrovirus vector for gene therapy
CA2298102A1 (en) * 1997-07-30 1999-02-11 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening

Also Published As

Publication number Publication date
WO2001007646A3 (en) 2001-05-17
WO2001007646A2 (en) 2001-02-01

Similar Documents

Publication Publication Date Title
AU3867400A (en) Methods of using bioelastomers
AU2297001A (en) Telestrator system
AU6109400A (en) Atomizer system
AU6197600A (en) Tactiovisual distance-to-exit exit-finding system
AU7902400A (en) Method for the preparation of 5-carboxyphthalide
AU5869900A (en) Uv-imager system
AU6909200A (en) Piggybac transformation system
AU6256600A (en) Wheelchair system
AU7268000A (en) Method for quantization of the antiviral effect of antiviral active principles
AU5691800A (en) Structure
AU6976100A (en) Self retaining nut
AU2201501A (en) Structure
AU4596200A (en) Wheelchair
AU2829700A (en) Processes for the preparation of alpha-aminoketones
AU1130901A (en) Method for the preparation of 5-carboxyphthalide
AU6001200A (en) Expression system
AU6028900A (en) Method for the preparation of urea
AU4755200A (en) Cycloalkyl substituted 3-urea-benzofurane-and -pyridofurane-derivatives
AU5120100A (en) Active booster transformer system
AU5081300A (en) High definition transducer
AU2190301A (en) Ranging system
AUPQ067299A0 (en) Atomiser
AU5552200A (en) Method
AU4616699A (en) Hydromagnetotherapy system
AU1161901A (en) Spray technology improvement

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 15, NO 20, PAGE(S) 4277-4282 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 55195/00, 55520/00, 58398/00, 61747/00, 63220/00, 63241/00, 63242/00, 65762/00, 65763/00, 65769/00, 68242/00, 70053/00, 70054/00, 70065/00, 70076/00 AND 72680/00

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase